Rotavirus Community Remains Committed To Ensuring Cost-Effectiveness, Accessibility Of Vaccines, PATH Associate Says

PATH’s “DefeatDD Blog”: Measuring the Next Mile for Rotavirus Vaccines
Laura Edison Kallen, senior scientific communications associate at PATH, discusses takeaways from the 13th International Rotavirus Symposium, writing, “[The symposium attendees] presented evidence and shared experiences to help ensure that rotavirus vaccines remain cost-effective, affordable, and accessible in this changing global environment. … The rotavirus community is still as committed as ever to improving coverage and providing the best possible protection to every child” (9/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.